The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Extended treatment with adjuvant imatinib (IM) for patients (pts) with high-risk primary gastrointestinal stromal tumor (GIST): The PERSIST-5 study.
 
Chandrajit P. Raut
No Relationships to Disclose
 
N. Joseph Espat
No Relationships to Disclose
 
Robert G. Maki
Honoraria - Lilly
Consulting or Advisory Role - AADi; Arcus Ventures; Bayer; Eisai; Gem Pharmaceuticals; Immune Design; Karyopharm Therapeutics; Lilly/ImClone; Presage Biosciences; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Immune Design (Inst); Lilly (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Bayer/Onyx; Immune Design; TRACON Pharma
 
Dejka M. Araujo
No Relationships to Disclose
 
Toni Faith Williams
Employment - Novartis
Travel, Accommodations, Expenses - Novartis
 
Johannes E. Wolff
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Ronald P. DeMatteo
No Relationships to Disclose